ConductScience.org, home

Paper688281

Adriamycin therapy for advanced ovarian carcinoma recurrent after chemotherapy.

Hubbard SM and 2 others. Cancer Treat Rep, 1978. Cited by 58 papers, by iCite.

Cite this record

ConductScience Library. Adriamycin therapy for advanced ovarian carcinoma recurrent after chemotherapy. Papers, record 688281. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/688281

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Adriamycin therapy for advanced ovarian carcinoma recurrent after chemotherapy.
PubMed
Journal
Cancer Treat Rep
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
58
iCite
Relative citation ratio, by iCite
3.05
iCite
Revised in PubMed
2013-11-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hubbard SMS M
2Barkes PP
3Young RCR C

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CarcinomaMajor topic
DoxorubicinMajor topic
Ovarian NeoplasmsMajor topic
Adult
Aged
Drug Evaluation
Female
Humans
Middle Aged
Neoplasm Recurrence, Local

Source PubMed

Download CSV of topics

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.

PMIDTitleJournalYearIn PapersSource
23198277Pegylated liposomal doxorubicin/carboplatin combination in ovarian cancer, progressing on single-agent pegylated liposomal doxorubicin.World J Clin Oncol2012https://conductscience.org/library/papers/23198277PubMed
11986767A phase I dose-finding study of a combination of pegylated liposomal doxorubicin (Doxil), carboplatin and paclitaxel in ovarian cancer.Br J Cancer2002https://conductscience.org/library/papers/11986767PubMed
6371015Developing new drugs for ovarian cancer: a challenging task in a changing reality.J Cancer Res Clin Oncol1984https://conductscience.org/library/papers/6371015PubMed
6172215Chemotherapy of ovarian cancer directed by the human tumor stem cell assay.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/6172215PubMed
3858013Identification of anthracycline analogues with enhanced cytotoxicity and lack of cross-resistance to adriamycin using a series of mammalian cell lines in vitro.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/3858013PubMed
3459509The in vitro effects and cross-resistance patterns of some novel anthracyclines.Br J Cancer1986https://conductscience.org/library/papers/3459509PubMed
2557300Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced epithelial carcinoma of the ovary: a Gynecologic Oncology Group study.Invest New Drugs1989https://conductscience.org/library/papers/2557300PubMed
2478178The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer.Br J Cancer1989https://conductscience.org/library/papers/2478178PubMed
2295117A phase II study of oral idarubicin in advanced recurrent or refractory ovarian carcinoma.Cancer Chemother Pharmacol1990https://conductscience.org/library/papers/2295117PubMed
2272774Phase II study of esorubicin (4'deoxydoxorubicin) in anthracycline naive patients with ovarian cancer.Invest New Drugs1990https://conductscience.org/library/papers/2272774PubMed
1834291Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.BMJ1991https://conductscience.org/library/papers/1834291PubMed
1503894Implications of an overview of chemotherapy in advanced ovarian carcinoma.Br J Cancer1992https://conductscience.org/library/papers/1503894PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/688281

GET https://conductscience.org/api/papers/v1/688281/authors